Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05251311 · ClinicalTrials.gov registry record · NA
A Mixed-Method Evaluation of the Impact of Social Risk Screening on Uptake of Social Assistance
A NA study, sponsored by Children's Hospital of Philadelphia.
- Completed
- Registry status
- NA
- Development phase
- 3,949
- Enrollment target
NCT05251311: Completed NA study, sponsored by Children's Hospital of Philadelphia.
NCT05251311 is a NA study that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 3,949 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (181% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05251311, a NA study, has completed, sponsored by Children's Hospital of Philadelphia.
- COMPLETED
- Registry status
- NA
- Development phase
- 3,949 participants
- Enrollment target
Study Summary
Children are disproportionately affected by the rise in poverty rates in the United States. Economic hardships can compromise child development, overall health, and the ability to succeed in school and in life. The current economic recession and racial disparities underscored by COVID19 have magnified this impact on children and hastened the already rapid growth of screening protocols for social risk factors- such as food and housing insecurity, financial strain, and unsafe environments-within pediatric health care. However, it remains unclear what effect standardized screening has on family perception of and engagement with resources. Current implementation momentum for screening protocols is outpacing research, and is raising concern among patient advocates for unintended harm-alienating families for fear of stigma or worse, and overpromising services that may not exist. Through a rigorous mixed-method approach, the proposed study will explore the impact of screening on acceptance, perception, and engagement with social resources among families with children. Furthermore, by leveraging the new technology of resource mapping as the method of resource referral, this study will provide insight regarding its effectiveness as a social needs assistance strategy. The knowledge gained will provide guidance for policymakers and other healthcare systems on how to integrate social risk interventions into healthcare delivery in order to maximize the benefit to children and families.
Primary Outcome
total number of searches
Interventions
- BEHAVIORAL Social Risk Screening Tool
- OTHER Electronic Resource Map
- BEHAVIORAL Resource Menu
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,949 participants |
| Start Date | 2022-04-19 |
| Est. Completion | 2023-09-22 |
| Phase | NA |
What the finished NCT05251311 record still lists
NCT05251311 is an interventional study that assigns participants to a tested intervention. Its 3,949 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (181% higher).
The record links to 0 conditions, and to 3 interventions - of which Social Risk Screening Tool is the first listed.
NCT05251311 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05251311 about?
NCT05251311 is a clinical study titled "A Mixed-Method Evaluation of the Impact of Social Risk Screening on Uptake of Social Assistance". Children are disproportionately affected by the rise in poverty rates in the United States. Economic hardships can compromise child development, overall health, and the ability to succeed in school and in life. The current economic recession and racial disparities underscored by COVID19 have magnifi...
What is the current status of trial NCT05251311?
This trial is currently completed. It is a NA study. The enrollment target is 3,949 participants. The study started on 2022-04-19. Estimated completion is 2023-09-22.
What interventions are being tested in trial NCT05251311?
The interventions under investigation include: Social Risk Screening Tool (BEHAVIORAL), Electronic Resource Map (OTHER), Resource Menu (BEHAVIORAL).
Who is sponsoring clinical trial NCT05251311?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05251311's enrollment target sits among peer trials
3,949 36th of 2000 higher than 1,965 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05879926 · 3,960 participants · Phase 3
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
- NCT03936335 · 3,930 participants
An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis (AD)
- NCT05919342 · 3,904 participants · NA
Screening for earlY Heart Failure Diagnosis and Management in Primary Care or at HOme Using Natriuretic Peptides and echocardiographY "SYMPHONY-HF"
- NCT00227253 · 4,000 participants
Chromosome 18 Clinical Research Center
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI